Last10K.com

Therapy Cells Inc (TCEL) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

Therapy Cells Inc

HISTORY TOOLS
CIK: 1429859 Ticker: TCEL

View differences made from one year to another to evaluate Therapy Cells Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Therapy Cells Inc.

Continue

Assess how Therapy Cells Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Therapy Cells Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Therapy Cells Inc provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Certification Of Chief Financial Officer
Exhibit 32.1: Certification Of Chief Executive Officer And Chief Financial Officer
Ticker: TCEL
CIK: 1429859
Form Type: 10-K Annual Report
Accession Number: 0001683168-19-003240
Submitted to the SEC: Fri Oct 11 2019 5:02:36 PM EST
Accepted by the SEC: Fri Oct 11 2019
Period: Saturday, December 31, 2011
Industry: Wholesale Jewelry Watches Precious Stones And Metals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tcel/0001683168-19-003240.htm